Coperchini et al. proposed that COVID-19 patients have high levels of the pro-inflammatory cytokines IL-1β, IL-6, TNF-α, INF-γ and chemokines CXCL10, CXCL9 levels (Coperchini et al., 2020). This evidence concerns the gene IL6 and COVID-19.